NovoCure's Total Current Liabilities rose 557.88% to $776.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $776.0 million, marking a year-over-year increase of 557.88%. This contributed to the annual value of $756.4 million for FY2024, which is 32228.51% up from last year.
Latest data reveals that NovoCure reported Total Current Liabilities of $776.0 million as of Q3 2025, which was up 557.88% from $749.6 million recorded in Q2 2025.
Over the past 5 years, NovoCure's Total Current Liabilities peaked at $776.0 million during Q3 2025, and registered a low of $110.5 million during Q1 2021.
Over the past 5 years, NovoCure's median Total Current Liabilities value was $157.2 million (recorded in 2023), while the average stood at $304.3 million.
Per our database at Business Quant, NovoCure's Total Current Liabilities soared by 36767.46% in 2024 and then skyrocketed by 557.88% in 2025.
NovoCure's Total Current Liabilities (Quarter) stood at $142.6 million in 2021, then rose by 11.34% to $158.8 million in 2022, then increased by 12.81% to $179.1 million in 2023, then surged by 322.29% to $756.4 million in 2024, then increased by 2.6% to $776.0 million in 2025.
Its Total Current Liabilities stands at $776.0 million for Q3 2025, versus $749.6 million for Q2 2025 and $743.3 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value